000			01905cam a22004574a 4500
008			130618s2008 ne af b 001 0 eng
010			_a2007-035586
016	7		_a101315286 _2DNLM
020			_a9780123695208 (alk. paper)
020			_a0123695201 (alk. paper)
035			_avtls010520811
039		9	_y201306180819 _zmschk03
040			_aDNLM/DLC _cDLC _dNLM _dBAKER _dBTCTA _dYDXCP _dC#P _dBWX _dDLC _dSTUSCHK1
042			_apcc
060	1	0	_aQV 744 _bK395d 2008
080	0	0	_a615/.19 _222
100	1		_aKerns, Edward Harvel.
245	1	0	_aDrug-like properties : _bconcepts, structure design and methods : from ADME to toxicity optimization _cEdward H. Kerns and Li Di.
260			_aAmsterdam ; _aBoston _bAcademic Press _c2008.
300			_axix, 526 p., [2] p. of plates _bill. (some col.) _c27 cm.
504			_aIncludes bibliographical references (p. 492) and index.
650		0	_aPharmaceutical chemistry.
650		0	_aDrugs _xStructure-activity relationships.
650		0	_aDrug development.
650		0	_aDrugs _xDesign.
650	1	2	_aDrug Design.
650	2	2	_aDrug Evaluation, Preclinical.
650	2	2	_aDrug Toxicity.
650	2	2	_aPharmaceutical Preparations _xmetabolism.
650	2	2	_aPharmacokinetics.
650	2	2	_aStructure-Activity Relationship.
700	1		_aDi, Li.
856	4	1	_3Table of contents only _uhttp://www.loc.gov/catdir/toc/ecip0726/2007035586.html
856	4	2	_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0811/2007035586-d.html
906			_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg
910			_aSCHK95
919			_a978-0-1236-9520-8
925	1		_aacquire _b1 shelf copy _xpolicy default
955			_djc18 2007-09-04 _ejc18 2007-09-04 to Dewey _fjx09 2008-02-27 Z-CipVer _gjx09 2008-02-27 c. 1-2 to BCCD
999			_c6977 _d6977